TRMT6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.985200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.874800E-01
Normal-vs-Stage2
9.594400E-01
Normal-vs-Stage3
2.137800E-01
Normal-vs-Stage4
5.827400E-01
Stage1-vs-Stage2
4.792600E-01
Stage1-vs-Stage3
2.094400E-02
Stage1-vs-Stage4
9.158200E-01
Stage2-vs-Stage3
8.527500E-02
Stage2-vs-Stage4
5.173000E-01
Stage3-vs-Stage4
3.602500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.533400E-01
Normal-vs-AfricanAmerican
7.518800E-01
Normal-vs-Asian
5.322600E-01
Caucasian-vs-AfricanAmerican
7.113400E-01
Caucasian-vs-Asian
2.228400E-01
AfricanAmerican-vs-Asian
2.085800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.723000E-01
Normal-vs-Female
9.778000E-01
Male-vs-Female
8.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.091200E-01
Normal-vs-Age(41-60Yrs)
6.992400E-01
Normal-vs-Age(61-80Yrs)
8.378600E-01
Normal-vs-Age(81-100Yrs)
9.546400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.055000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.262800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.226800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.307600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.297600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.109000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.053600E-01
Normal-vs-Daily Drinker
6.251200E-01
Normal-vs-Weekly Drinker
9.130800E-01
Normal-vs-Occasional Drinker
1.891210E-01
Normal-vs-Social Drinker
9.609800E-01
Non Drinker-vs-Daily Drinker
9.134400E-01
Non Drinker-vs-Weekly Drinker
3.765800E-01
Non Drinker-vs-Occasional Drinker
2.239100E-03
Non Drinker-vs-Social Drinker
5.481000E-01
Daily Drinker-vs-Weekly Drinker
3.290400E-01
Daily Drinker-vs-Occasional Drinker
9.411800E-04
Daily Drinker-vs-Social Drinker
4.777400E-01
Weekly Drinker-vs-Occasional Drinker
1.168250E-01
Weekly Drinker-vs-Social Drinker
7.854200E-01
Occasional Drinker-vs-Social Drinker
3.733800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.084200E-01
Normal-vs-Grade 2
9.096000E-01
Normal-vs-Grade 3
8.779200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.811000E-01
Grade 1-vs-Grade 3
6.548600E-01
Grade 1-vs-Grade 4
9.084200E-01
Grade 2-vs-Grade 3
5.286600E-01
Grade 2-vs-Grade 4
9.096000E-01
Grade 3-vs-Grade 4
8.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.150800E-01
Normal-vs-NonDiabetic
9.871000E-01
Diabetic-vs-NonDiabetic
4.694000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.859000E-01
Normal-vs-NoPancreatitis
9.724800E-01
Pancreatitis-vs-NoPancreatitis
4.274200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.795000E-01
Normal-vs-N1
9.332000E-01
N0-vs-N1
4.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.986800E-01
Normal-vs-TP53-NonMutant
8.485800E-01
TP53-Mutant-vs-TP53-NonMutant
5.654000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
